Literature DB >> 18791273

HA14-1 is able to reconstitute the impaired mitochondrial pathway of apoptosis in renal cell carcinoma cell lines.

Sebastian Heikaus1, Linda van den Berg, Tobias Kempf, Csaba Mahotka, Helmut Erich Gabbert, Uwe Ramp.   

Abstract

Renal cell carcinomas (RCCs) exhibit a marked resistance towards apoptosis. Although most apoptotic stimuli converge at the level of the mitochondria, little is known about the mitochondrial apoptosis pathway in renal cell carcinomas. The aim of the present study, therefore, was to investigate the functionality of the mitochondrial apoptosis pathway in renal cell carcinoma cell lines by exposure to TRAIL, etoposide, HA14-1 and betulinic acid activating the mitochondria by different mechanisms. Sensitivity to TRAIL-induced apoptosis correlated with cleavage of the initiator caspase-8, but the mitochondrial apoptosis pathway was not induced. Similarly, etoposide and betulinic acid could not induce mitochondrial damage. In contrast, HA14-1 was able to activate mitochondrial apoptosis, thereby demonstrating functionally inducible signalling pathways downstream of the mitochondria. The intactness of the pathways upstream of the mitochondria was shown by pretreatment of TRAIL-sensitive cell lines with HA14-1, which could reconstitute TRAIL-induced mitochondrial damage and resulted in a synergistic apoptosis induction. Our results demonstrate that the apoptotic pathways upstream and downstream of the mitochondria are intact and inducible in renal cell carcinoma cell lines. However, resistance towards mitochondrial apoptosis is located on the level of the mitochondria themselves.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18791273      PMCID: PMC4618985          DOI: 10.3233/clo-2008-0438

Source DB:  PubMed          Journal:  Cell Oncol        ISSN: 1570-5870            Impact factor:   6.730


  4 in total

1.  The role of apoptosis repressor with a CARD domain (ARC) in the therapeutic resistance of renal cell carcinoma (RCC): the crucial role of ARC in the inhibition of extrinsic and intrinsic apoptotic signalling.

Authors:  Csaba Toth; Sarah Funke; Vanessa Nitsche; Anna Liverts; Viktoriya Zlachevska; Marcia Gasis; Constanze Wiek; Helmut Hanenberg; Csaba Mahotka; Peter Schirmacher; Sebastian Heikaus
Journal:  Cell Commun Signal       Date:  2017-05-02       Impact factor: 5.712

2.  Apoptosis of t(14;18)-positive lymphoma cells by a Bcl-2 interacting small molecule.

Authors:  David R Abbott; Robert T Abbott; Stephen D Jenson; G Chris Fillmore; Kojo S J Elenitoba-Johnson; Megan S Lim
Journal:  J Hematop       Date:  2009-02-28       Impact factor: 0.196

3.  2,4-Dihydroxy-3'-methoxy-4'-ethoxychalcone suppresses cell proliferation and induces apoptosis of multiple myeloma via the PI3K/akt/mTOR signaling pathway.

Authors:  FengChen Zhu; DianMing Jiang; MingHua Zhang; Bo Zhao
Journal:  Pharm Biol       Date:  2019-12       Impact factor: 3.503

Review 4.  Treatment Strategies that Enhance the Efficacy and Selectivity of Mitochondria-Targeted Anticancer Agents.

Authors:  Josephine S Modica-Napolitano; Volkmar Weissig
Journal:  Int J Mol Sci       Date:  2015-07-29       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.